AAOS issues position statement on stem cell, biologic treatments: 4 things to know

Written by Megan Wood | December 21, 2017 | Print  |

The American Academy of Orthopaedic Surgeons published a new position statement, "Use of Emerging Biologic Therapies."

Here are four things to know:

1. The statement alerts physicians and patients about understanding the risks and benefits associated with stem cell and biologic treatments for musculoskeletal joint conditions.


2. Specifically, the position statement reads: "surgeons should be cognizant of the risks, benefits, regulatory status and labeled indications of the products they use."


3. AAOS also highlights "Orthopaedic Surgical Consent" and "Standards of Professionalism" guidelines in the position statement.


4. AAOS concludes the statement by calling on orthopedic surgeons and hospitals to contribute biologic treatment efficacy data to registries.


More articles on biologics:
Bone Biologics reports positive preclinical results for its spine growth factor: 4 insights
Fuse Medical to acquire CPM Medical Consultants — 5 takeaways
HSS' Dr. Christopher Mendias earns $800k grant for stem cell research — 5 notes

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months